FERRO INTRAVENOSO EM INSUFICIÊNCIA CARDÍACA COM DEFICIÊNCIA DE FERRO: UMA REVISÃO SISTEMÁTICA ENTRE CARDIOLOGIA E HEMATOLOGIA
LUMEN ET VIRTUS · 17.07.2026 · 17 (62) · e13816
DOI: 10.56238/levv17n62-032 ↗Kurz gefasst
Fachartikel in der Zeitschrift LUMEN ET VIRTUS, online erschienen am 17.07.2026. Verfasst von Antonio Fachini Sanches Fernandes und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Iron deficiency is a frequent and clinically relevant comorbidity in heart failure, even in the absence of anemia, and is associated with impaired exercise capacity, worse symptoms, reduced quality of life, and increased risk of hospitalization. Intravenous iron has been proposed as a therapeutic strategy capable of bypassing the limitations of oral iron absorption and restoring iron availability in patients with heart failure and laboratory-defined iron deficiency.
Objective
The main objective of this systematic review was to evaluate the efficacy and safety of intravenous iron therapy in patients with heart failure and iron deficiency. Secondary objectives included assessment of heart failure hospitalization, cardiovascular mortality, all-cause mortality, functional capacity, quality of life, hematological response, safety, certainty of evidence, and practical implications for multidisciplinary care.
Methods
A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform. Eligible studies included randomized clinical trials and clinically relevant comparative studies evaluating intravenous iron in adult patients with heart failure and iron deficiency. Data were synthesized narratively because of clinical heterogeneity in heart failure phenotype, iron formulation, dosing strategy, follow-up duration, and endpoint definitions. Results and Discussion: Six randomized clinical trials were included in the final review. Intravenous ferric carboxymaltose and ferric derisomaltose generally improved functional capacity, symptoms, and quality of life, with the most consistent event-based benefit involving reduction in heart failure hospitalizations. Mortality reduction was not demonstrated consistently, and the certainty of evidence was higher for symptomatic and hospitalization-related outcomes than for cardiovascular or all-cause mortality. The safety profile was generally acceptable when intravenous iron was administered to appropriately selected patients with confirmed iron deficiency.
Conclusion
Intravenous iron is an evidence-based therapeutic option for selected patients with heart failure and iron deficiency, particularly those with reduced or mildly reduced left ventricular ejection fraction, persistent symptoms, impaired functional capacity, or recurrent hospitalization. Its use should be individualized and integrated into multidisciplinary heart failure management, with careful interpretation of ferritin, transferrin saturation, anemia status, renal function, and competing causes of fatigue or functional decline.
Zitieren
APA
Fernandes, A. F. S., André, M. L. M., Pedroso, L. D. P., Döbeli, L., Vieira, S. S., & Figueiredo, E. F. D. (2026). FERRO INTRAVENOSO EM INSUFICIÊNCIA CARDÍACA COM DEFICIÊNCIA DE FERRO: UMA REVISÃO SISTEMÁTICA ENTRE CARDIOLOGIA E HEMATOLOGIA. LUMEN ET VIRTUS, 17(62), e13816. https://doi.org/10.56238/levv17n62-032
Vancouver
Fernandes AFS, André MLM, Pedroso LDP, Döbeli L, Vieira SS, Figueiredo EFD. FERRO INTRAVENOSO EM INSUFICIÊNCIA CARDÍACA COM DEFICIÊNCIA DE FERRO: UMA REVISÃO SISTEMÁTICA ENTRE CARDIOLOGIA E HEMATOLOGIA. LUMEN ET VIRTUS. 2026;17(62):e13816. doi:10.56238/levv17n62-032
BibTeX
@article{Fernandes2026,
author = {Fernandes, Antonio Fachini Sanches and André, Maria Luiza Martins and Pedroso, Laura dos Passos and Döbeli, Leticia and Vieira, Sunamita Souza and Figueiredo, Eduardo Fanelli de},
title = {FERRO INTRAVENOSO EM INSUFICIÊNCIA CARDÍACA COM DEFICIÊNCIA DE FERRO: UMA REVISÃO SISTEMÁTICA ENTRE CARDIOLOGIA E HEMATOLOGIA},
journal = {LUMEN ET VIRTUS},
year = {2026},
volume = {17},
number = {62},
pages = {e13816},
doi = {10.56238/levv17n62-032}
}
EUVIMED